Client News

Abivax announces the success of its oversubscribed capital increase of EUR 28m at market price

Verona Pharma plc: Verona Pharma Provides Update on AIM Delisting

XPHYTO Therapeutics announces RT-PCR test for point-of-care COVID-19 detection

Eternygen Announces the First Closing of its Series A2 Funding Round

Allecra Therapeutics Announces Late-breaker Presentation of Phase 3 ALLIUM Trial with Cefepime-Enmetazobactam in cUTIs at IDWeek 2020

Verona Pharma plc: Verona Pharma to Announce Interim Results for the Three and Nine Months Ended September 30, 2020 and Provide Corporate Update

CENTOGENE GmbH: CENTOGENE gibt Führungswechsel bekannt

Atriva Therapeutics GmbH: Germany: EIB backs Atriva Therapeutics with €24 million for the development of a potential COVID-19 treatment

HepaRegeniX GmbH hires industry veteran Dr David Shapiro as Senior Medical Advisor

Adocia Announces Third Quarter 2020 Financial Results